BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23992236)

  • 21. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors.
    Strenger V; Sovinz P; Lackner H; Dornbusch HJ; Lingitz H; Eder HG; Moser A; Urban C
    Strahlenther Onkol; 2008 May; 184(5):276-80. PubMed ID: 18427759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
    Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary results of conformal radiation therapy for medulloblastoma.
    Merchant TE; Happersett L; Finlay JL; Leibel SA
    Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cavernous malformations after whole-brain radiotherapy in primitive neuroectodermal tumor patients-comparing susceptibility-weighted imaging and T2 gradient-echo sequences.
    Khasminsky V; Yalon M; Greenberg G; Tsarfaty G; Atar E; Hoffmann C
    Neuroradiology; 2018 Sep; 60(9):913-919. PubMed ID: 30030548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation.
    Radcliffe J; Bunin GR; Sutton LN; Goldwein JW; Phillips PC
    Int J Dev Neurosci; 1994 Jun; 12(4):327-34. PubMed ID: 7976487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
    Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
    J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
    Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medulloblastoma in childhood: Impact of radiation technique upon the outcome of treatment.
    Chojnacka M; Skowrońska-Gardas A
    Pediatr Blood Cancer; 2004 Feb; 42(2):155-60. PubMed ID: 14752880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of cerebral microbleeds after cranial irradiation in medulloblastoma patients.
    Roongpiboonsopit D; Kuijf HJ; Charidimou A; Xiong L; Vashkevich A; Martinez-Ramirez S; Shih HA; Gill CM; Viswanathan A; Dietrich J
    Neurology; 2017 Feb; 88(8):789-796. PubMed ID: 28122904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
    Eaton BR; Esiashvili N; Kim S; Patterson B; Weyman EA; Thornton LT; Mazewski C; MacDonald TJ; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Neuro Oncol; 2016 Jun; 18(6):881-7. PubMed ID: 26688075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?
    Padovani L; Chapon F; André N; Boucekine M; Geoffray A; Bourdeau F; Masliah-Planchon J; Claude L; Huchet A; Laprie A; Supiot S; Coche-Dequéant B; Kerr C; Alapetite C; Leseur J; Nguyen T; Chapet S; Bernier V; Bondiau PY; Noel G; Habrand JL; Bolle S; Doz F; Dufour C; Muracciole X; Carrie C
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):980-986. PubMed ID: 29485078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
    Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
    Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience.
    Tsang DS; Sarhan N; Ramaswamy V; Nobre L; Yee R; Taylor MD; Hawkins C; Bartels U; Huang A; Tabori U; Hodgson DC; Bouffet E; Laperriere N
    J Neurooncol; 2019 Oct; 145(1):107-114. PubMed ID: 31468270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome and prognostic factors of radiation therapy for medulloblastoma.
    Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
    J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.